Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lexicon Pharmaceuticals (LXRX) Net Income towards Common Stockholders: 2009-2011

Historic Net Income towards Common Stockholders for Lexicon Pharmaceuticals (LXRX) over the last 3 years, with Dec 2011 value amounting to -$33.8 million.

  • Lexicon Pharmaceuticals' Net Income towards Common Stockholders fell 47.16% to -$33.8 million in Q4 2011 from the same period last year, while for Dec 2011 it was -$115.1 million, marking a year-over-year decrease of 16.06%. This contributed to the annual value of -$116.2 million for FY2011, which is 14.19% down from last year.
  • As of Q4 2011, Lexicon Pharmaceuticals' Net Income towards Common Stockholders stood at -$33.8 million, which was down 29.66% from -$26.1 million recorded in Q3 2011.
  • Over the past 5 years, Lexicon Pharmaceuticals' Net Income towards Common Stockholders peaked at -$20.9 million during Q3 2009, and registered a low of -$33.8 million during Q4 2011.
  • Its 3-year average for Net Income towards Common Stockholders is -$25.4 million, with a median of -$24.6 million in 2010.
  • The largest annual percentage gain for Lexicon Pharmaceuticals' Net Income towards Common Stockholders in the last 5 years was 5.12% (2011), contrasted with its biggest fall of 47.16% (2011).
  • Over the past 3 years, Lexicon Pharmaceuticals' Net Income towards Common Stockholders (Quarterly) stood at -$21.8 million in 2009, then decreased by 5.43% to -$23.0 million in 2010, then crashed by 47.16% to -$33.8 million in 2011.
  • Its Net Income towards Common Stockholders stands at -$33.8 million for Q4 2011, versus -$26.1 million for Q3 2011 and -$26.7 million for Q2 2011.